Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Elisaf

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
Archives of Internal Medicine|May 29, 2000
Hypernatremia in hospitalized patients: a sequel of inadvertent fluid administrationH J Milionis, G Liamis, M S Elisaf
Expert Opinion on Pharmacotherapy|June 14, 2016
Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitorsT D Filippatos, V Tsimihodimos, M S Elisaf
International Journal of Clinical Practice|January 5, 2008
Ezetimibe-associated adverse effects: what the clinician needs to knowM Florentin, E N Liberopoulos, M S Elisaf
Haematologica|May 1, 1997
Pronounced electrolyte abnormalities in a patient with acute leukemiaM S Elisaf, K Burads, K C Siamopoulos
The American Journal of Medicine|October 7, 2000
Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozilG Alexandridis, G A Pappas, M S Elisaf
Postgraduate Medical Journal|May 29, 2000
Hypersensitivity syndrome caused by amitriptyline administrationH J Milionis, A Skopelitou, M S Elisaf
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 2, 1999
Effect of fenofibrate on serum uric acid levelsG Liamis, E T Bairaktari, M S Elisaf
Journal of Internal Medicine|April 4, 2001
Appropriate treatment of hypernatraemia in diabetic hyperglycaemic hyperosmolar syndromeH J Milionis, G Liamis, M S Elisaf
Diabetes & Metabolic Syndrome|June 18, 2018
SGLT2 inhibitors and the kidney: Effects and mechanismsV Tsimihodimos, T D Filippatos, M S Elisaf
American Journal of Nephrology|January 1, 1996
Chronic hyponatremia due to reset osmostat in a patient with colon cancerM S Elisaf, A Konstantinides, K C Siamopoulos
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Archives of Internal Medicine|May 29, 2000
Hypernatremia in hospitalized patients: a sequel of inadvertent fluid administrationH J Milionis, G Liamis, M S Elisaf
Expert Opinion on Pharmacotherapy|June 14, 2016
Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitorsT D Filippatos, V Tsimihodimos, M S Elisaf
International Journal of Clinical Practice|January 5, 2008
Ezetimibe-associated adverse effects: what the clinician needs to knowM Florentin, E N Liberopoulos, M S Elisaf
Haematologica|May 1, 1997
Pronounced electrolyte abnormalities in a patient with acute leukemiaM S Elisaf, K Burads, K C Siamopoulos
The American Journal of Medicine|October 7, 2000
Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozilG Alexandridis, G A Pappas, M S Elisaf
Postgraduate Medical Journal|May 29, 2000
Hypersensitivity syndrome caused by amitriptyline administrationH J Milionis, A Skopelitou, M S Elisaf
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 2, 1999
Effect of fenofibrate on serum uric acid levelsG Liamis, E T Bairaktari, M S Elisaf
Journal of Internal Medicine|April 4, 2001
Appropriate treatment of hypernatraemia in diabetic hyperglycaemic hyperosmolar syndromeH J Milionis, G Liamis, M S Elisaf
Diabetes & Metabolic Syndrome|June 18, 2018
SGLT2 inhibitors and the kidney: Effects and mechanismsV Tsimihodimos, T D Filippatos, M S Elisaf
American Journal of Nephrology|January 1, 1996
Chronic hyponatremia due to reset osmostat in a patient with colon cancerM S Elisaf, A Konstantinides, K C Siamopoulos
Pageof 15